This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Learn timing cues for selecting an SP 500 ETF versus an index fund in retirement to optimize outcomes.
25,797 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
BlackRock signals that a new youth-savings framework, dubbed Trump Accounts, could help jump-start saving for educati...
A 70-year-old aims to generate $69,600 a year from a $1.1 million portfolio, testing whether higher-yield income stra...
Rising financed jewelry debt is reshaping family budgets and investment plans. Experts say debt consolidation seldom ...
As summer approaches, investors debate whether the market is primed for a rally or headed for a slump. This guide bre...
If Kevin Warsh becomes Fed chair, rate moves could stay higher for longer. This detailed guide shows how that scenari...
A market thinker known as the prophet ‘wired belt’ warns that AI-driven shifts are hollowing out knowledge-economy jo...
Ripple vaults onto CNBC’s disruptor list, while XRP trades in a tight range. The token hovered around $1.35 as market...
Broadcom surges after expanding its custom-chip partnership with Apple through 2031, boosting peers like AMD and Inte...
Bitcoin stabilizes in the mid-30s thousands as ETF demand persists, with Ethereum and XRP offering measured upside on...
XRP is flashing warnings on-chain as sellers keep control, with Open Interest near lows and outflows signaling fading...
Despite regulatory progress and new market access, XRP has struggled to break out in 2026. This piece analyzes whethe...